Dare Bioscience, Inc.
DARE· Nasdaq
DAREDare Bioscience, Inc.
Filed Apr 1, 2019 · 10-K · 91 days after period end · 0001401914-19-000015
derived · Computed from the longer spans the company filed.
| Metric | Q4 2018dderived from reported figures | Q4 2017dderived from reported figures | Q4 2016 | Q4 2015 |
|---|---|---|---|---|
| Revenue | — | — | $766.00K | — |
| Net Income | -$2.92M | -$9.13M | -$4.95M | -$10.72M |
| EPS Diluted | — | — | -$0.17 | -$0.39 |
Dare Bioscience, Inc. · CIK 1401914 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2018 · filed Apr 1, 2019 · 91 d after period end
